Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

This publication has 49 references indexed in Scilit:

• Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain
  Journal of the Neurological Sciences, 1987
• Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
  Annals of Neurology, 1986
• Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1986
• Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP ⁺ Binds to Neuromelanin
  Science, 1986
• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
  Nature, 1985
• Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
  Neurology, 1985
• Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
  European Journal of Pharmacology, 1984
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Biochemical and Biophysical Research Communications, 1984
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979